Markets › India › NSE › GLENMARK

Glenmark Pharmaceuticals Ltd

NSE:GLENMARKHealthcareNSE:CNX200NSE:CNX500

₹2,210.20−0.74%At closeAt close · Mon 19 Oct · ≈ AED 85.28 · Market cap $6.62B · Next earnings Fri 6 Nov

Report	EPS estimate	EPS actual	EPS surprise	Revenue estimate (m)	Revenue actual (m)	Revenue surprise
2026-07-31	17.30	17.11	−1.1%	39,160.0	40,184.8	+2.6%
2026-06-01	18.20	10.68	−41.3%	38,133.3	37,705.9	−1.1%
2026-05-29	18.30	10.88	−40.5%	38,133.3	38,426.9	+0.8%
2026-02-12	18.70	14.28	−23.6%	38,329.5	39,006.2	+1.8%
2026-01-29	18.70	14.28	−23.6%	34,355.1	39,006.2	+13.5%
2025-11-14	—	21.57	—	37,214.3	60,468.7	+62.5%
2025-08-13	12.90	1.66	−87.1%	35,182.1	32,644.4	−7.2%
2025-05-26	12.06	10.37	−14.0%	33,642.1	32,201.3	−4.3%
2025-05-23	12.10	8.75	−27.7%	33,743.3	32,562.0	−3.5%
2025-02-13	14.05	12.30	−12.5%	34,350.7	33,876.0	−1.4%
2024-11-14	14.70	12.55	−14.6%	34,890.3	34,338.0	−1.6%
2024-10-24	14.81	12.64	−14.7%	35,147.1	34,005.0	−3.2%